Drinking 1 cup of caffeinated coffee a day might help lower a person's risk of recurrent AFib episodes by as much as 39%, a ...

Yi Wu, PhD, OT, from the Department of Neurology and Edmarie Guzmán-Vélez, PhD, of the Department of Psychiatry at Mass ...

Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy ...

Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.30404 EPS, expectations were $-0.04. Operator ...

Different scientific fields have their own ways of evaluating validity. Engineers test new designs against safety and performance standards. Medical researchers use controlled experiments to verify ...

ARC Raiders is a third person extraction shooter set on a post-apocalyptic Earth where robotic enemies have taken over the ...

Company achieved FDA alignment on Phase 3 Oz-V trial for the treatment of 2L+ OPSCC, which will evaluate dual primary ...

The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical outcomes.

Q3 2025 Earnings Call Transcript November 10, 2025 Myomo, Inc. beats earnings expectations. Reported EPS is $-0.09, ...

Do ultra-processed foods increase type 2 diabetes risk? Explore the link between what we eat and diabetes rates in this ...

Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors November 8:00 ...

Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections ...